Ligand validation:6RME

IMP: INOSINIC ACID

IMP is a Ligand Of Interest in 6RME designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6RME_IMP_D_501	56%	31%	0.165	0.937	1.52	1.37	2	3	2	0	100%	1
6RME_IMP_F_501	55%	33%	0.177	0.947	1.5	1.24	2	4	1	0	100%	1
6RME_IMP_H_501	49%	33%	0.17	0.919	1.51	1.27	2	4	3	0	100%	1
6RME_IMP_E_501	41%	33%	0.207	0.923	1.49	1.27	2	4	2	0	100%	1
6RME_IMP_C_501	41%	32%	0.205	0.92	1.53	1.26	2	5	3	0	100%	1
6RME_IMP_B_501	27%	33%	0.248	0.897	1.51	1.26	2	5	1	0	100%	1
6RME_IMP_A_501	26%	32%	0.223	0.867	1.5	1.31	2	4	3	0	100%	1
6RME_IMP_G_501	26%	33%	0.197	0.84	1.5	1.25	2	5	2	0	100%	1
6RMW_IMP_C_501	38%	34%	0.162	0.865	1.49	1.24	2	5	5	0	100%	1
2C6Q_IMP_E_1337	98%	21%	0.06	0.984	1.94	1.53	5	6	3	0	100%	1
5UWX_IMP_C_501	98%	35%	0.06	0.984	1.3	1.35	3	2	2	0	100%	1
5UZC_IMP_D_500	98%	31%	0.06	0.981	1.35	1.51	2	3	1	0	100%	1
5UPV_IMP_A_601	98%	35%	0.06	0.979	1.39	1.27	2	3	1	0	100%	1
7PVO_IMP_A_501	97%	33%	0.063	0.981	1.48	1.28	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.